We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr CEO: Generic Biologics Still Years Away
Barr CEO: Generic Biologics Still Years Away
May 13, 2005
Barr Laboratories CEO Bruce Downey remains confident that the FDA will eventually establish a pathway for biogenerics, but he concedes that follow-on biologics are still at least three years away from becoming a reality in the U.S.